Sanofi-Synthelabo To Maintain Device Subsidiaries Following Merger
This article was originally published in The Gray Sheet
Executive Summary
The medical device holdings of a consolidated Sanofi-Synthelabo will be retained in the foreseeable future, according to the companies.